Literature DB >> 31043183

Design, implementation, and analysis considerations for cluster-randomized trials in infection control and hospital epidemiology: A systematic review.

Lyndsay M O'Hara1, Natalia Blanco1, Surbhi Leekha1, Kristen A Stafford1, Gerard P Slobogean2, Emilie Ludeman3, Anthony D Harris1.   

Abstract

BACKGROUND: In cluster-randomized trials (CRT), groups rather than individuals are randomized to interventions. The aim of this study was to present critical design, implementation, and analysis issues to consider when planning a CRT in the healthcare setting and to synthesize characteristics of published CRT in the field of healthcare epidemiology.
METHODS: A systematic review was conducted to identify CRT with infection control outcomes.
RESULTS: We identified the following 7 epidemiological principles: (1) identify design type and justify the use of CRT; (2) account for clustering when estimating sample size and report intraclass correlation coefficient (ICC)/coefficient of variation (CV); (3) obtain consent; (4) define level of inference; (5) consider matching and/or stratification; (6) minimize bias and/or contamination; and (7) account for clustering in the analysis. Among 44 included studies, the most common design was CRT with crossover (n = 15, 34%), followed by parallel CRT (n = 11, 25%) and stratified CRT (n = 7, 16%). Moreover, 22 studies (50%) offered justification for their use of CRT, and 20 studies (45%) demonstrated that they accounted for clustering at the design phase. Only 15 studies (34%) reported the ICC, CV, or design effect. Also, 15 studies (34%) obtained waivers of consent, and 7 (16%) sought consent at the cluster level. Only 17 studies (39%) matched or stratified at randomization, and 10 studies (23%) did not report efforts to mitigate bias and/or contamination. Finally, 29 studies (88%) accounted for clustering in their analyses.
CONCLUSIONS: We must continue to improve the design and reporting of CRT to better evaluate the effectiveness of infection control interventions in the healthcare setting.

Entities:  

Mesh:

Year:  2019        PMID: 31043183      PMCID: PMC6897299          DOI: 10.1017/ice.2019.48

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  16 in total

Review 1.  Design and analysis issues in cluster-randomized trials of interventions against infectious diseases.

Authors:  R J Hayes; N D Alexander; S Bennett; S N Cousens
Journal:  Stat Methods Med Res       Date:  2000-04       Impact factor: 3.021

Review 2.  Ethical issues in the design and conduct of cluster randomised controlled trials.

Authors:  S J Edwards; D A Braunholtz; R J Lilford; A J Stevens
Journal:  BMJ       Date:  1999-05-22

Review 3.  Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals.

Authors:  Suezann Puffer; David Torgerson; Judith Watson
Journal:  BMJ       Date:  2003-10-04

4.  Pitfalls of and controversies in cluster randomization trials.

Authors:  Allan Donner; Neil Klar
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

5.  Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials.

Authors:  Agnès Caille; Sally Kerry; Elsa Tavernier; Clémence Leyrat; Sandra Eldridge; Bruno Giraudeau
Journal:  BMJ       Date:  2016-08-16

Review 6.  Cluster-randomized controlled trials evaluating complex interventions in general practices are mostly ineffective: a systematic review.

Authors:  Andrea Siebenhofer; Michael A Paulitsch; Gudrun Pregartner; Andrea Berghold; Klaus Jeitler; Christiane Muth; Jennifer Engler
Journal:  J Clin Epidemiol       Date:  2017-10-31       Impact factor: 6.437

7.  Randomization by cluster. Sample size requirements and analysis.

Authors:  A Donner; N Birkett; C Buck
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

8.  Methods for sample size determination in cluster randomized trials.

Authors:  Clare Rutterford; Andrew Copas; Sandra Eldridge
Journal:  Int J Epidemiol       Date:  2015-07-13       Impact factor: 7.196

9.  How to design efficient cluster randomised trials.

Authors:  K Hemming; S Eldridge; G Forbes; C Weijer; M Taljaard
Journal:  BMJ       Date:  2017-07-14

10.  Consort 2010 statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Gilda Piaggio; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2012-09-04
View more
  1 in total

1.  Influential methods reports for group-randomized trials and related designs.

Authors:  David M Murray
Journal:  Clin Trials       Date:  2022-01-06       Impact factor: 2.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.